Jamp-montelukast 10mg: May Contain Foreign Fragments Of Pink Candesartan Tablets

JAMP-MONTELUKAST 10mg Recall JAMP-Montelukast 10mg tablets are being recalled in Canada because some bottles may contain fragments of pink candesartan tablets, which is a different medication. The contamination happened during manufacturing. This recall applies to all JAMP-Montelukast 10mg products distributed across Canada.

Product

JAMP-MONTELUKAST 10mg

Reason

Contamination

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2025-04-24

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/6930f517-bce5-47ff-8f01-ae5faf0ec318